Table 3.
Outcome | Overall (n = 25) | Group 1 (n = 12) | Group 2 (n = 13) | P value |
Morbidity | ||||
Bleeding | 4 (16.0) | 1 (8.3) | 3 (23.1) | 0.590 |
Wound infection | 3 (12.0) | 3 (25.0) | 0 (0.0) | 0.100 |
Acute kidney injury | 4 (16.0) | 2 (16.7) | 2 (15.4) | 1.000 |
Short bowel syndrome | 5 (20.0) | 5 (41.7) | 0 (0.0) | 0.020 |
Secondary portal hypertension | 1 (4.0) | 1 (8.3) | 0 (0.0) | 0.480 |
Cavernous transformation of the portal vein | 2 (8.0) | 2 (16.7) | 0 (0.0) | 0.220 |
Delayed or secondary operation | 6 (24.0) | 2 (16.7) | 4 (30.8) | 0.650 |
Bowel transmural necrosis | 2 (8.0) | 0 (0.0) | 2 (15.4) | 0.480 |
Bowel perforation | 1 (4.0) | 1 (8.3) | 0 (0.0) | 0.480 |
Bowel stricture | 3 (12.0) | 1 (8.3) | 2 (15.4) | 1.000 |
Laparoscopic surgery | 4 (16.0) | 0 (0.0) | 4 (30.8) | 0.100 |
Length of resection (cm)2 | 100 (range: 0, 155) | 155 (105, 200) | 0 (0, 65) | < 0.001 |
Time from treatment to symptom elimination1 | 12.52 ± 7.85 | 18.25 ± 7.69 | 7.23 ± 2.42 | < 0.001 |
Time from admission to enteral or oral nutrition (d)1 | 14.48 ± 6.98 | 20.50 ± 5.13 | 8.92 ± 1.89 | < 0.001 |
Duration of hospitalization in (d)1 | 31.28 ± 15.51 | 43.00 ± 13.77 | 20.46 ± 6.59 | < 0.001 |
Total cost in RNB1 | 133895.20 ± 90996.47 | 200020.40 ± 91505.62 | 72785.60 ± 21828.16 | 0.001 |
< 30-d mortality | 24 (96.0) | 11 (91.7) | 0 (0.0) | 0.480 |
1-yr survival | 21 (84.0) | 9 (75.0) | 12 (92.3) | 0.320 |
Analysis was performed by t test;
Mann-Whitney U test; or Fisher’s exact test.